Consultation
We ask for feedback on proposals through public consultation, and take all consultation responses we receive into account before making our decisions.
We welcome feedback from pharmaceutical suppliers, health professionals, health interest groups and the general public. This page includes consultations that are currently underway.
You can respond to consultation by writing to the address at the bottom of the consultation letter.
Rapid response
If you would like to make a rapid response to any of our consultations, 
click here. Remember to indicate which consultation proposal your comments relate to.
Search for previous consultations documents
- Proposal to amend restrictions on three pain and antinausea medications - closes 18 September 2008 (3 pages, 132 KB) 03 Sep 2008
- Proposal to amend restrictions on nervous system pharmaceuticals - closes 15 September 2008 (3 pages, 47 KB) 29 Aug 2008
- Quinapril & Quinapril with Hydrochlorothiazide - closes 12 September 2008 (2 pages, 113 KB) 29 Aug 2008
- Removal of the dipyridamole Special Authority - closes 12 September 2008 (2 pages, 137 KB) 29 Aug 2008
- Proposal for Strattera, Humalog Mix, Zyprexa and Actos - closes 11 September 2008 (3 pages, 235 KB) 27 Aug 2008
- Voluntary checklist for health consumer organisations - closes 24 October 2008 (8 pages, 387 KB) 27 Aug 2008
- Special foods supplied by Nestle - proposed changes to some funded products - closes 8 September 2008 (2 pages, 80 KB) 25 Aug 2008
Page updated on 05 Sep 2008
Linked documents
Proposal to amend restrictions on three pain and antinausea medications - closes 18 September 2008 (3 pages, 132 KB)
2 September 2008 Proposal to amend restrictions on three pain and antinausea medications Proposal summary PHARMAC is seeking feedback on a proposal to amend restrictions applying to the subsidy for fentanyl transdermal patches, gabapentin and betahistine dihydrochloride, with effect from…
Proposal to amend restrictions on nervous system pharmaceuticals - closes 15 September 2008 (3 pages, 47 KB)
29 August 2008 Proposal to amend restrictions on nervous system pharmaceuticals Proposal summary PHARMAC is seeking feedback on a proposal to amend restrictions applying to the subsidy for several nervous system pharmaceuticals, with effect from 1 December 2008. Access to…
Quinapril & Quinapril with Hydrochlorothiazide - closes 12 September 2008 (2 pages, 113 KB)
29 August 2008 Proposal regarding quinapril (Accupril) and quinapril with hydrochlorothiazide (Accuretic) Summary As a result of a Request for Proposals for the sole supply of quinapril and quinapril with hydrochlorothiazide (dated 18 June 2008), PHARMAC and Pfizer New Zealand…
Removal of the dipyridamole Special Authority - closes 12 September 2008 (2 pages, 137 KB)
29 August 2008 Proposal to remove the dipyridamole Special Authority Proposal Summary PHARMAC is seeking feedback on a proposal to remove the Special Authority restriction that currently applies to both strengths of dipyridamole in the Pharmaceutical Schedule. The proposal would…
Proposal for Strattera, Humalog Mix, Zyprexa and Actos - closes 11 September 2008 (3 pages, 235 KB)
27 August 2008 Proposal for Strattera (atomoxetine), Humalog Mix 25 and Humalog Mix 50 (insulin lispro with insulin lispro protamine suspension), Zyprexa and Zyprexa Zydis (olanzapine), and Actos (pioglitazone) Proposal summary PHARMAC and Eli Lilly have entered into a provisional…
Voluntary checklist for health consumer organisations - closes 24 October 2008 (8 pages, 387 KB)
CAC Consumer Advisory Committee Voluntary Checklist for Health Consumer Organisations Entering into Health Industry Sponsorship Draft for Consultation Contents 1. Introduction 1. Guiding principles to consider if entering into health industry sponsorship: 2. Checklist 2. Deciding whether to enter into…
Special foods supplied by Nestle - proposed changes to some funded products - closes 8 September 2008 (2 pages, 80 KB)
25 August 2008 Special foods supplied by Nestle: proposed changes to some funded products PHARMAC is seeking feedback on a provisional agreement with Nestle Healthcare Nutrition to replace the currently listed Isosource and Fibresource brands of enteral feed (with and…
